Hui Zhang
Northwestern University · 859 works · 19,555 citations · h-index 63
Top works
- Weekly nab -Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients
- Less is More: Compact Matrix Decomposition for Large Sparse Graphs
- The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate
- Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B
- Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
- Introduction to mediation analysis with structural equation modeling.
- Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus
- Proteogenomic and metabolomic characterization of human glioblastoma
- 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS
- Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial
- Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
- Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice
- Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials
- Kappa coefficient: a popular measure of rater agreement
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
- Distinct TCR signaling pathways drive proliferation and cytokine production in T cells
- Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
- Noisy iris image matching by using multiple cues